Charlotte Byrd
Family · Mobile, ALNPI 1285225987
Payments from drug & device makers
Across 192 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$513
- Incyte Corporation$476
- Johnson & Johnson$382
- Daiichi Sankyo Inc.$268
- Merck$263
- Eisai Inc.$256
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,69798%
- Education$832%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 27 | $513 |
| Incyte Corporation | 22 | $476 |
| Johnson & Johnson | 21 | $382 |
| Daiichi Sankyo Inc. | 12 | $268 |
| Merck | 13 | $263 |
| Eisai Inc. | 13 | $256 |
| Lilly USA, LLC | 11 | $214 |
| AstraZeneca(2 entities) | 9 | $168 |
| Stemline Therapeutics Inc. | 6 | $130 |
| Pfizer | 6 | $103 |
| Seagen Inc. | 2 | $97 |
| Genentech USA, Inc. | 5 | $91 |
| Sanofi | 5 | $87 |
| Tersera Therapeutics LLC | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Amgen | 4 | $60 |
| Array Biopharma Inc | 4 | $59 |
| Bristol Myers Squibb | 2 | $45 |
| AbbVie | 2 | $38 |
| Sobi, Inc | 2 | $34 |
| Pharmaessentia USA Corporation | 2 | $34 |
| Boehringer Ingelheim | 2 | $31 |
| Beone Medicines USA, Inc. | 2 | $31 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Immunocore Limited | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $20 |
| Morphosys, US Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| CSL Behring | 1 | $17 |
| Syndax Pharmaceuticals, Inc. | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Taiho Oncology, Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,780 in reported general payments places this provider in the 85th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 125 | $5,176 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 80 | $4,066 |
| Fentanyl | 36 | $3,943 |
| Morphine Sulfate ErMorphine Sulfate | 70 | $3,871 |
| Gabapentin | 208 | $2,692 |
| Oxycodone Hcl | 85 | $2,253 |
| Pregabalin | 32 | $1,150 |
| Hydromorphone Hcl | 35 | $1,051 |
| Mirtazapine | 35 | $1,026 |
| Methadone Hcl | 28 | $986 |
| Promethazine Hcl | 25 | $380 |
| Ondansetron Hcl | 23 | $374 |
| Duloxetine Hcl | 11 | $274 |
| Methocarbamol | 14 | $199 |
| Zolpidem Tartrate | 14 | $89 |
Paid to pharmacies, not to this prescriber.
Other family in Mobile
- Christopher LovellMobile$64K
- Sanjyot BhadkamkarMobile$16K
- Freda SmithMobile$14K
- Alexandria HellmichMobile$13K
- Kara BoutwellMobile$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.